TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 3, 2025 TG Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.15, ...
Q4 2024 TG Therapeutics Inc Earnings Call
Greetings and welcome to the TG Therapeutics fourth quarter and full year conference call and webcast. (Operator Instructions). As a reminder, this conference is being recorded. It's all my pleasure ...
TG Therapeutics targets $525M BRIUMVI revenue in 2025 while advancing subcutaneous formulation and pivotal trials
Management provided guidance of $115 million in U.S. BRIUMVI net revenue for Q1 2025 and reiterated the full-year 2025 target of $525 million. January and February 2025 were noted as the highest ...